Retrouvez ci-dessous la veille bibliographique élaborée par notre groupe pour le mois de décembre 2023 !

• Towards a new role for multimodality imaging in the diagnosis of cancer-associated marantic endocarditis | Lire l’article ARCHIVES OF CARDIOVASCULAR DISEASES
• Timing of exercise therapy when initiating adjuvant chemotherapy for breast cancer: a randomized trial | Lire l’article EUROPEAN HEART JOURNAL
• Association of radiation dose to cardiac substructures with major ischaemic events following breast cancer radiotherapy | Lire l’article EUROPEAN HEART JOURNAL
• Cardio-Oncology Rehabilitation for Cancer Survivors With High Cardiovascular Risk: A Randomized Clinical Trial | Lire l’article JAMA NETWORK
• Cardio-Oncology Rehabilitation Programs—The Next Phase in Improving Care for Cancer Survivors | Lire l’article JAMA NETWORK
• Priorities in Cardio-Oncology Basic and Translational Science: GCOS 2023 Symposium Proceedings: JACC: CardioOncology State-of-the-Art Review | Lire l’articleJACC
• Cancer-Associated Thrombosis: Trends in Clinical Features, Treatment, and Outcomes From 2001 to 2020 | Lire l’article JACC
• Cardiovascular Events After Hematopoietic Stem Cell Transplant: Incidence and Risk Factors | Lire l’article JACC
• Incidence of Radiation-Associated Cancer in Patients With Congenital Heart Disease | Lire l’article THE AMERICAN JOURNAL OF CARDIOLOGY
• Gene-Level Analysis of Anthracycline-Induced Cardiomyopathy in Cancer Survivors: A Report From COG-ALTE03N1, BMTSS, and CCSS | Lire l’article JACC
• Incidence of MACE in Patients Treated With CAR-T Cell Therapy: A Prospective Study | Lire l’article JACC
• Increased Cardiac Risk After a Second Malignant Neoplasm Among Childhood Cancer Survivors: A FCCSS Study | Lire l’article JACC
• Predicting Adverse Cardiac Events After Radiotherapy for Locally Advanced Non–Small Cell Lung Cancer | Lire l’article JACC
• Risk of Ischemic Heart Disease in Patients With Postpancreatectomy Diabetes and Pancreatic Cancer: A Population‐Based Study | Lire l’article JAHA
• Severe vs Nonsevere Immune Checkpoint Inhibitor-Induced Myocarditis: Contemporary 1-Year Outcomes | Lire l’article JACC